Literature DB >> 2547025

Relationship between electrocortical activity and beta-adrenergic receptor function in the rat after chronic desimipramine treatment.

F N Krijzer1, J Schipper, M T Tulp, P A Koopman.   

Abstract

The aim of this study was to investigate the effects of chronic administration of desimipramine (DMI) after 2, 7 or 20 mg/kg per day, administered by osmotic minipumps, on electrocortical activity and beta-adrenergic receptors in rat brain. Rats receiving DMI chronically show a dose- and time-dependent increase of electrocortical activity above 15 Hz as well as a dose- and time-dependent decrease below 15 Hz. Already after 3 days of treatment a clear effect on the electrocorticogram (ECoG) was seen. The maximal change in the ECoG was reached at the end of the study, after 24 days of treatment. After acute treatment (20 and 45 minutes after 2, 4 or 10 mg/kg i.p.) with DMI, a decrease of electrocortical activity is seen above 15 Hz. Thus the effect of acute DMI treatment on the ECoG is different from that of chronic treatment. In the same group of rats the effect of chronic DMI treatment on the beta-adrenergic receptor number was determined 24 hours after the last ECoG recording. The number of beta-adrenergic receptors was dose dependently reduced in the DMI-treated rats as determined by [3H]-dihydroalprenolol binding. There was no change in affinity (KD) of the ligand for the beta-receptor. This finding was corroborated by a decrease in the functional activity of the beta-adrenergic receptors, as determined by isoprenaline stimulated efflux of cyclic-AMP in cortex slices. These data indicate that chronic treatment with DMI, resulting in a down-regulation of the cortical beta-adrenergic system, is paralleled by pronounced effects on the ECoG of rats. The different ECoG profiles after chronic DMI treatment compared with acute treatment suggest that adaptive changes in the electrical brain activity continually develop during the chronic treatment with this antidepressant drug.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547025     DOI: 10.1007/BF01247115

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  41 in total

1.  Down-regulation of serotonin2, but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and beta-adrenergic receptors.

Authors:  J A Scott; F T Crews
Journal:  Neuropharmacology       Date:  1986-12       Impact factor: 5.250

2.  Variability of chronic antidepressant treatments on beta-adrenergic receptor sites.

Authors:  B E Suranyi-Cadotte; T V Dam; S Bodnoff; R Quirion
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1985       Impact factor: 5.067

3.  Analysis of one-component saturable systems such as ligand binding, enzyme kinetic, uptake, and transport data.

Authors:  J A Zivin; D R Waud
Journal:  J Pharmacol Methods       Date:  1986-08

4.  Long-term desipramine treatment attenuates clonidine-induced suppression of ventral tegmental self-stimulation.

Authors:  C S Aulakh; R M Cohen; S N Pradhan; D L Murphy
Journal:  Life Sci       Date:  1985-02-04       Impact factor: 5.037

5.  Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants.

Authors:  P D Hrdina
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

6.  Effects of chronic amitriptyline and desipramine on food intake and body weight in rats.

Authors:  J N Nobrega; D V Coscina
Journal:  Pharmacol Biochem Behav       Date:  1987-05       Impact factor: 3.533

7.  A study of the effects of clonidine on the EEG in rats treated with single and multiple doses of antidepressants.

Authors:  W Kostowski; W Dyr; B Zacharski
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Effect of desipramine, phenoxybenzamine and yohimbine on beta-adrenoceptors and cyclic AMP production in the rat brain.

Authors:  I C Campbell; R M McKernan; R W Smokcum; J D Stephenson; T B Weeramanthri
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

9.  EEG evaluation of drug effects in the rat.

Authors:  A Glatt; T Duerst; B Mueller; H Demieville
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

10.  Quantitative analysis of the EEG effects produced by imipramine, desipramine promazine, and monodesmethyl promazine in the isolated perfused rat brain.

Authors:  H Rieger; J Krieglstein
Journal:  Psychopharmacologia       Date:  1974
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.